Login

CEO Erik Kinnman presents Sprint Bioscience - Erik Kinnman, CEO, Sprint Bioscience 00:00:00

Share On Facebook Share On Twitter

CEO Erik Kinnman presents Sprint Bioscience

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating the Allergy Therapeutics landscape: Insights into Market Expansion and Financial Strength |Manuel Llobet, CEO, Allergy Therapeutics PLC.
00:10:00
Plateau Uranium: Leading Lithium-Uranium Exploration in Peru, Fueling Green Energy Future
00:10:00
Empowering Digital Success: Tools and Insights for Wealth Management Strategies by Lee Francis at CREALOGIX | Oliver Weber, Chief Executive Officer of Crealogix Holding AG
00:10:00
Fernando Cirne Offers Expert CEO Advice on Leading Locaweb | Fernando Cirne, CEO , Locaweb Serviços De Internet SA.
00:10:00
Gaining Perspective: Market Insights & Strategies Part 2 | George Smith, co-CEO and Chief Investment Officer of Smith Bruer Advisors
00:10:00
A Soldier's Commitment to Family and Country|Col. Patrick Biggs
00:00:00
BOT Investor Webinar | 26 September 2023 - Vince Ippolito Executive Chairman, Botanix Pharmaceuticals Ltd
00:10:00
EVS renews its partnership with the HERA Awards | Interview with Serge Van Herck, CEO of EVS.
00:10:00
Emerald Resources MD Morgan Hart Presents Progress on Okvau Gold Project
00:10:00
David Bernstein Reflects on Post-October 7 Changes in Jewish Community and Academia|David L. Bernstein, Professor, George Mason University School of Law
00:10:00
Leveraging SOA for Information Integrity, Cost Efficiency, and Streamlined Global Development
00:10:00
Accelerate transatlantic expansion for B2B software companies in both the U.S. and Europe|Zoe Chambers,Partner,Frontline Ventures

© 2017 - Neuhu+